Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Total 13F shares
-
2,129,596
-
Share change
-
+1,801,647
-
Total reported value
-
$915,427
-
Price per share
-
$0.43
-
Number of holders
-
17
-
Value change
-
+$790,701
-
Number of buys
-
13
-
Number of sells
-
2
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q3 2024
As of 30 Sep 2024,
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,129,596 shares.
The largest 10 holders included
MAI Capital Management, UBS Group AG, MORGAN STANLEY, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, UNITED BANK, JPMORGAN CHASE & CO, COMMONWEALTH EQUITY SERVICES, LLC, RHUMBLINE ADVISERS, and XTX Topco Ltd.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.